September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Inhibition of corneal inflammation by a small peptide derived from human pancreatitis-associated protein
Author Affiliations & Notes
  • Xun Xu
    Ophthalmology, Shang Hai First People's Hospital, Shanghai, China
  • Shaopin Zhu
    Ophthalmology, Shang Hai First People's Hospital, Shanghai, China
  • Xiaolu Yang
    Ophthalmology, Shang Hai First People's Hospital, Shanghai, China
  • Footnotes
    Commercial Relationships   Xun Xu, None; Shaopin Zhu, None; Xiaolu Yang, None
  • Footnotes
    Support  National Natural Science Foundation of China(81273424)
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 5407. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Xun Xu, Shaopin Zhu, Xiaolu Yang; Inhibition of corneal inflammation by a small peptide derived from human pancreatitis-associated protein. Invest. Ophthalmol. Vis. Sci. 2016;57(12):5407.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : JY-8 is a novel 16-amino-acid peptide indentified from human pancreatitis-associated protein (PAP), a protein with protective effect against inflammatory diseases. In this study, we investigated the effect of JY-8 on poly(I:C) and LPS induced keratitis using in vitro and in vivo assays.

Methods : ELISA and RT-PCR were used to test the expression of cytokines; Clinical scoring and histological study were used to evaluate the inflammatory reaction of the cornea in vivo; The expression of ICAM-1 and phosphorylation of IKKα/β / IκBα / NF-κB was detected by immunofluorescence and immunoblot analyses.

Results : Our results suggested that JY-8 suppressed the poly(I:C) and LPS-induced mRNA and protein expression of interleukin (IL)-1beta, IL-6, IL-8 and monocyte chemotactic protein (MCP)-1 in the corneal fibroblasts in vitro(P < 0.01 vs. the PBS group), inhibited the clinical manifestation, neutrophil infiltration, and expression of inflammatory cytokines in the cornea. We also demonstrated the possible mechanism of JY-8 on keratitis was through interrupting the NF-κB pathway.

Conclusions : JY-8, a novel peptide derived from human protein, may be a promising and safe drug for therapeutic application for corneal inflammation.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×